A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

Published:2011-01 Issue:1 Volume:9 Page:36-41.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Kotlyar David S.,Osterman Mark T.,Diamond Robert H.,Porter David,Blonski Wojciech C.,Wasik Mariusz,Sampat Sami,Mendizabal Manuel,Lin Ming V.,Lichtenstein Gary R.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update;Mackey;J Pediatr Gastroenterol Nutr,2009

2. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease;Mackey;J Pediatr Gastroenterol Nutr,2007

3. Hepatosplenic T cell lymphoma in inflammatory bowel disease;Shale;Gut,2008

4. Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment;Falchook;Ann Oncol,2009

5. Data on file, Centocor, Inc, Horsham, PA.

Cited by 405 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database;Frontiers in Pharmacology;2024-09-12

2. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary;Clinical Gastroenterology and Hepatology;2024-07

3. Medicinal Mishap: Thiopurines and risk of lymphoproliferative disorders;Australian Prescriber;2024-06-18

4. Medical management of pediatric inflammatory bowel disease;Seminars in Pediatric Surgery;2024-04

5. Update on T-Cell Lymphoma Epidemiology;Current Hematologic Malignancy Reports;2024-03-07